-
-
-
-
-
-
-
Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
-
-
-
-
-
-
-
Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
-
-
-
-
-
-
-
Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
-
-
-
-
-
-
-
Onco-Innovations plans $2 million private placement at $0.88 per unit
-
-
-
-
-
-
-
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
-
-
-
-
-
-
-
Onco-Innovations Announces Closing of Private Placement
-
-
-
-
-
-
-
Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care
-
458,133 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

